Activating mutations of Ret have been linked to cancer, i.e., somatic chromosomal rearrangements result in Papillary Thyroid Carcinoma, point mutations of RET lead to Multiple Endocrine Neoplasia 2 syndrome and RET is also differentially expressed in acute myeloid leukaemia [13], [14]. Here, RET is linked to acute myeloid leukemia.